112475-20-4

Upstream product

• 87357-65-1 (3R)-3-hydroxytetradecanoic acid phenacyl ester 
• 112-64-1 tetradecanoyl chloride 
• 76062-97-0 methyl (R)-3-hydroxytetradecanoate 
• 22348-97-6 methyl 3-oxotetradecanoate 
• 143-07-7 lauric acid 
• 28715-21-1 (R)-3-hydroxytetradecanoic acid 

Downstream Products

• 111247-06-4 benzyl 2-deoxy-4,6-O-isopropylidene-2-<(3R)-3-tetradecanoyloxytetradecanamido>-β-D-glucopyranoside 
• 111247-19-9 benzyl 3-O-<(3R)-3-(benzyloxymethoxy)tetradecanoyl>-2-deoxy-4-O-(diphenylphosphono)-2-<(3R)-3-tetradecanoyloxytetradecanamido>-β-D-glucopyranoside 
• 112475-28-2 (R)-3-Tetradecanoyloxy-tetradecanoic acid (2R,3R,4R,5S,6R)-2-benzyloxy-3-((R)-3-benzyloxymethoxy-tetradecanoylamino)-5-hydroxy-6-trityloxymethyl-tetrahydro-pyran-4-yl ester 
• 111247-27-9 (R)-3-Benzyloxymethoxy-tetradecanoic acid (2R,3R,4R,5S,6R)-2-benzyloxy-5-hydroxy-3-((R)-3-tetradecanoyloxy-tetradecanoylamino)-6-trityloxymethyl-tetrahydro-pyran-4-yl ester 
• 111247-24-6 benzyl 2-<(3R)-3-(benzyloxymethoxy)tetradecanamido>-2-deoxy-4,6-O-isopropylidene-3-O-<(3R)-3-tetradecanoyloxytetradecanoyl>-β-D-glucopyranoside 
• 111266-71-8 benzyl 3-O-<(3R)-3-(benzyloxymethoxy)tetradecanoyl>-2-deoxy-4,6-O-isopropylidene-2-<(3R)-3-tetradecanoyloxytetradecanamido>-β-D-glucopyranoside 
• 112475-27-1 (R)-3-Tetradecanoyloxy-tetradecanoic acid (2R,3R,4R,5S,6R)-2-benzyloxy-3-((R)-3-benzyloxymethoxy-tetradecanoylamino)-5-hydroxy-6-hydroxymethyl-tetrahydro-pyran-4-yl ester 
• 111247-16-6 (R)-3-Benzyloxymethoxy-tetradecanoic acid (2R,3R,4R,5S,6R)-2-benzyloxy-5-hydroxy-6-hydroxymethyl-3-((R)-3-tetradecanoyloxy-tetradecanoylamino)-tetrahydro-pyran-4-yl ester 
• 111247-08-6 (R)-3-Tetradecanoyloxy-tetradecanoic acid (2R,3R,4R,5S,6R)-2-benzyloxy-5-hydroxy-3-((R)-3-tetradecanoyloxy-tetradecanoylamino)-6-trityloxymethyl-tetrahydro-pyran-4-yl ester 
• 106022-67-7 benzyl 2-deoxy-2-<(R)-3-tetradecanoloxytetradecanamido>-3-O-<(R)-3-tetradecanoyloxytetradecanoyl>-β-D-glucopyranoside 
• 111247-07-5 benzyl 2-deoxy-4,6-O-isopropylidene-2-<(3R)-3-tetradecanoyloxytetradecanamido>-3-O-<(3R)-3-tetradecanoyloxytetradecanoyl>-β-D-glucopyranoside 
• 111275-43-5 benzyl 2-deoxy-4-O-(diphenoxyphosphinyl)-2-<(3R)-3-tetradecanoyloxytetradecanamido>-3-O-<(3R)-3-tetradecanoyloxytetradecanoyl>-β-D-glucopyranoside 
• 112475-29-3 benzyl 2-<(3R)-3-(benzyloxymethoxy)tetradecanamido>-2-deoxy-4-O-(diphenoxyphosphinyl)-3-O-<(3R)-3-tetradecanoyloxytetradecanoyl>-β-D-glucopyranoside 

Relevant academic research and scientific papers

SYNTHESIS OF THE OPTICALLY ACTIVE 4-O-PHOSPHONO-D-GLUCOSAMINE DERIVATIVES RELATED TO THE NONREDUCING-SUGAR SUBUNIT OF BACTERIAL LIPID A

The optically active lipid A-subunit homologs named GLA-46, GLA-47, GLA-59, and GLA-60 have been synthesized stepwise by successive acylation at N-2 and O-3 of benzyl 2-amino-2-deoxy-4,6-O-isopropylidene-β-D-glucopyranoside with the 3-O-(benzyloxy)methyl

SYNTHETIC GLUCOPYRANOSYL LIPID ADJUVANTS

PROBLEM TO BE SOLVED: To provide a novel glucopyranosyl lipid adjuvant (GLA) for inducing or enhancing immune responses, and a vaccine composition and a pharmaceutical composition comprising the GLA. SOLUTION: The present invention provides a GLA represented by a compound of the following formula, and a vaccine composition and a pharmaceutical composition comprising the GLA. SELECTED DRAWING: None COPYRIGHT: (C)2016,JPOandINPIT